Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086658
Status:
COMPLETED
Last Update Posted:
2020-05-05
First Post:
2004-07-07
Brief Title:
Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes HES
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline